Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Authors
Keywords
-
Journal
Nature Reviews Gastroenterology & Hepatology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-03-17
DOI
10.1038/s41575-023-00754-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study
- (2022) Nicolas Chong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Nonalcoholic steatohepatitis (NASH) cirrhosis: a snapshot of therapeutic agents in clinical development and the optimal design for clinical trials
- (2022) Pankaj Aggarwal et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
- (2022) Carla Montironi et al. GUT
- T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis
- (2022) Pierluigi Ramadori et al. HEPATOLOGY
- Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study.
- (2022) Shukui Qin et al. JOURNAL OF CLINICAL ONCOLOGY
- HCC Surveillance Improves Early Detection, Curative Treatment Receipt, and Survival in Patients with Cirrhosis: A Systematic Review and Meta-Analysis
- (2022) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- NAFLD indirectly impairs antigen-specific CD8+ T cell immunity against liver cancer in mice
- (2022) John C. McVey et al. iScience
- CXCR2 inhibition enables NASH-HCC immunotherapy
- (2022) Jack Leslie et al. GUT
- Metformin treatment rescues CD8+ T cell response to immune checkpoint inhibitor therapy in mice with NAFLD
- (2022) Simon Wabitsch et al. JOURNAL OF HEPATOLOGY
- Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis
- (2022) Darren Jun Hao Tan et al. LANCET ONCOLOGY
- Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids
- (2022) Jie Jian et al. Frontiers in Pharmacology
- Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
- (2022) Robin Kate Kelley et al. LANCET ONCOLOGY
- Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
- (2022) Andrew X. Zhu et al. NATURE MEDICINE
- Hepatocellular carcinoma
- (2022) Arndt Vogel et al. LANCET
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Treatment candidacy for pharmacologic therapies for NASH
- (2021) Ian A. Rowe et al. Clinical Gastroenterology and Hepatology
- Therapeutic pipeline in nonalcoholic steatohepatitis
- (2021) Raj Vuppalanchi et al. Nature Reviews Gastroenterology & Hepatology
- Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Gastroenterology & Hepatology
- Associations among adipose tissue immunology, inflammation and exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease
- (2021) Anja Fuchs et al. GASTROENTEROLOGY
- Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable Hepatocellular Carcinoma: The LEGACY Study
- (2021) Riad Salem et al. HEPATOLOGY
- Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
- (2021) Roser Pinyol et al. JOURNAL OF HEPATOLOGY
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
- (2021) Michael Dudek et al. NATURE
- Association of Obesity With Survival Outcomes in Patients With Cancer
- (2021) Fausto Petrelli et al. JAMA Network Open
- Sinusoidal endotheliopathy in nonalcoholic steatohepatitis: therapeutic implications
- (2021) Samar H. Ibrahim AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis
- (2021) Haley Schoenberger et al. Clinical Gastroenterology and Hepatology
- Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)
- (2021) Philipp K. Haber et al. GASTROENTEROLOGY
- Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma.
- (2021) Philipp K. Haber et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiology and risk-stratification of NAFLD-associated HCC
- (2021) George N. Ioannou JOURNAL OF HEPATOLOGY
- NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options
- (2021) Friedrich Foerster et al. JOURNAL OF HEPATOLOGY
- Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention
- (2021) Naomi F. Lange et al. JOURNAL OF HEPATOLOGY
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
- (2021) Zhenggang Ren et al. LANCET ONCOLOGY
- XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
- (2021) Aleksandra Deczkowska et al. NATURE MEDICINE
- Hepatocellular Carcinoma — Origins and Outcomes
- (2021) Robin K. Kelley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes after curative therapy for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a meta-analysis and review of current literature
- (2021) Ken M. Chin et al. HPB
- Key features of the environment promoting liver cancer in the absence of cirrhosis
- (2021) Marco Youssef William Zaki et al. Scientific Reports
- Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
- (2021) Tim F Greten et al. Journal for ImmunoTherapy of Cancer
- Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression
- (2021) Lorenzo A. Orci et al. Clinical Gastroenterology and Hepatology
- Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
- (2021) Jennifer R. Kramer et al. HEPATOLOGY
- Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
- (2021) Ramy Younes et al. JOURNAL OF HEPATOLOGY
- Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
- (2021) Thomas Yau et al. LANCET ONCOLOGY
- Convergent somatic mutations in metabolism genes in chronic liver disease
- (2021) Stanley W. K. Ng et al. NATURE
- Immunotherapies for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Advancing the global public health agenda for NAFLD: a consensus statement
- (2021) Jeffrey V. Lazarus et al. Nature Reviews Gastroenterology & Hepatology
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- (2021) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Expert Review
- (2020) Rohit Loomba et al. GASTROENTEROLOGY
- Risk of Cirrhosis and Hepatocellular Cancer in Patients with Non‐Alcoholic Fatty Liver Disease and Normal Liver Enzymes
- (2020) Yamini Natarajan et al. HEPATOLOGY
- Fibrosis and cancer: A strained relationship
- (2020) Bram Piersma et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
- (2020) Frank Jühling et al. GUT
- Utilization of hepatocellular carcinoma surveillance in patients with cirrhosis: A systematic review and meta‐analysis
- (2020) Erin Wolf et al. HEPATOLOGY
- Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort
- (2020) Quentin M. Anstee et al. JOURNAL OF HEPATOLOGY
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
- (2020) Tracey G. Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
- (2020) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Senolytic CAR T cells reverse senescence-associated pathologies
- (2020) Corina Amor et al. NATURE
- Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda
- (2020) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- Steatohepatitis Impairs T cell-directed Immunotherapies Against Liver Tumors in Mice
- (2020) Bernd Heinrich et al. GASTROENTEROLOGY
- Hepatitis C–Related Hepatocellular Carcinoma Incidence in the Veterans Health Administration After Introduction of Direct-Acting Antivirals
- (2020) Lauren A. Beste et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- rs641738C>T near MBOAT7 is associated with liver fat, ALT, and fibrosis in NAFLD: a meta-analysis
- (2020) Kevin Teo et al. JOURNAL OF HEPATOLOGY
- Maladaptive regeneration — the reawakening of developmental pathways in NASH and fibrosis
- (2020) Changyu Zhu et al. Nature Reviews Gastroenterology & Hepatology
- The genomic landscape of Mongolian hepatocellular carcinoma
- (2020) Julián Candia et al. Nature Communications
- Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH
- (2020) Kavita Jadhav et al. Frontiers in Endocrinology
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
- (2020) Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology
- Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
- (2020) Etienne Garin et al. Lancet Gastroenterology & Hepatology
- Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
- (2020) Cristiana Bianco et al. JOURNAL OF HEPATOLOGY
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
- (2019) Myriam Alexander et al. BMC Medicine
- Outcomes of Liver Transplantation for Non-alcoholic Steatohepatitis: a European Liver Transplant Registry Study
- (2019) Debashis Haldar et al. JOURNAL OF HEPATOLOGY
- Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification
- (2019) George N. Ioannou et al. JOURNAL OF HEPATOLOGY
- Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
- (2019) Mohsen Malehmir et al. NATURE MEDICINE
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
- (2019) Soumik BasuRay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diabetes is Associated with Increased Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
- (2019) Ju Dong Yang et al. HEPATOLOGY
- NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization
- (2019) Clemens Schotten et al. Liver Cancer
- Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study
- (2019) Samer Gawrieh et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: A propensity matched analysis
- (2019) Minyoung Kwak et al. AMERICAN JOURNAL OF SURGERY
- Liver Transplant for Hepatocellular Carcinoma in the United States: Evolving Trends over the Last Three Decades
- (2019) Marc Puigvehí et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
- (2019) Juliette Mouries et al. JOURNAL OF HEPATOLOGY
- Performance of Hong Kong Liver Cancer staging system in patients of hepatocellular carcinoma treated with surgical resection: An Indian validation study
- (2019) Shraddha Patkar et al. JOURNAL OF SURGICAL ONCOLOGY
- Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis
- (2019) Xuelian Xiong et al. MOLECULAR CELL
- Transarterial Chemoembolization of Hepatocellular Carcinoma: Propensity Score Matching Study Comparing Survival and Complications in Patients with Nonalcoholic Steatohepatitis Versus Other Causes Cirrhosis
- (2019) Shamar Young et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- TCT-472 Distribution of Coronary Flow Capacity Is Different Among the Groups by Abnormal CFR/HMR in Nonobstructive Coronary Artery Disease Patients
- (2019) Jin-Sin Koh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Resolving the fibrotic niche of human liver cirrhosis at single-cell level
- (2019) P. Ramachandran et al. NATURE
- Adaptive immunity: an emerging player in the progression of NAFLD
- (2019) Salvatore Sutti et al. Nature Reviews Gastroenterology & Hepatology
- The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids
- (2019) Sebastian Prill et al. Scientific Reports
- Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma
- (2019) William M. Kamp et al. Scientific Reports
- Mechanisms of Immune Tolerance in Liver Transplantation-Crosstalk Between Alloreactive T Cells and Liver Cells With Therapeutic Prospects
- (2019) Hong Lei et al. Frontiers in Immunology
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Editorial: NAFLD-related hepatocellular carcinoma - increasing or not? With or without cirrhosis?
- (2018) M. Balakrishnan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
- (2018) Kristina Tzartzeva et al. GASTROENTEROLOGY
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis
- (2018) Elizabeth Aby et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Pharmacotherapy for NASH: Current and emerging
- (2018) Monica A. Konerman et al. JOURNAL OF HEPATOLOGY
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer
- (2018) Takuma Tsuchida et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers
- (2018) Takahisa Kawaguchi et al. PLoS One
- Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
- (2018) Chi Ma et al. SCIENCE
- Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4+ T cell apoptosis promoting HCC development
- (2018) Zachary J. Brown et al. Cell Death & Disease
- Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases
- (2018) Jonathan G. Stine et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in murine non-alcoholic fatty liver disease
- (2018) Sander Lefere et al. HEPATOLOGY
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?
- (2018) Mark A. Febbraio et al. Cell Metabolism
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- Association of Physical Activity and Risk of Hepatobiliary Cancers: A Multinational Cohort Study
- (2018) Sebastian E. Baumeister et al. JOURNAL OF HEPATOLOGY
- The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2018) Konstantin Kazankov et al. Nature Reviews Gastroenterology & Hepatology
- Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
- (2018) Changyu Zhu et al. Science Translational Medicine
- Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling
- (2018) Jessie Qiaoyi Liang et al. Nature Communications
- High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation
- (2018) Barbara Kern et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
- (2017) Fasiha Kanwal et al. GASTROENTEROLOGY
- The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation
- (2017) Soumik BasuRay et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet
- (2017) Ayae Ikawa-Yoshida et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups
- (2017) Shiv Chitturi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity
- (2017) Shabnam Shalapour et al. NATURE
- Inflammation, metaflammation and immunometabolic disorders
- (2017) Gökhan S. Hotamisligil NATURE
- Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose–response meta-analysis
- (2017) Oliver John Kennedy et al. BMJ Open
- MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
- (2017) Benedetta Donati et al. Scientific Reports
- Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma
- (2016) Ana L. Gomes et al. CANCER CELL
- Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
- (2016) Sahil Mittal et al. Clinical Gastroenterology and Hepatology
- Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
- (2016) Riad Salem et al. GASTROENTEROLOGY
- The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
- (2016) Rosellina Margherita Mancina et al. GASTROENTEROLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
- (2016) Jérôme Boursier et al. HEPATOLOGY
- Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
- (2016) Fabio Piscaglia et al. HEPATOLOGY
- Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
- (2016) Daniel R. Wahl et al. JOURNAL OF CLINICAL ONCOLOGY
- A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
- (2016) Amon Asgharpour et al. JOURNAL OF HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
- (2016) Chi Ma et al. NATURE
- Classification and characterization of microsatellite instability across 18 cancer types
- (2016) Ronald J Hause et al. NATURE MEDICINE
- Clinical Presentation, Risk Factors, and Treatment Modalities of Hepatocellular Carcinoma: A Single Tertiary Care Center Experience
- (2016) Abdulrahman A. Aljumah et al. Gastroenterology Research and Practice
- Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma
- (2016) Yao-Yao Zhou et al. Scientific Reports
- Temporal Trends of Nonalcoholic Fatty Liver Disease–Related Hepatocellular Carcinoma in the Veteran Affairs Population
- (2015) Sahil Mittal et al. Clinical Gastroenterology and Hepatology
- Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease
- (2015) Venkatanarayana Gangarapu et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
- (2015) Jessica Zucman-Rossi et al. GASTROENTEROLOGY
- Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
- (2015) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
- (2015) Andrew X Zhu et al. LANCET ONCOLOGY
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- (2015) Joong-Won Park et al. LIVER INTERNATIONAL
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- Impact of Steatosis on Prognosis of Patients with Early-Stage Hepatocellular Carcinoma After Hepatic Resection
- (2014) Chien-Wei Su et al. ANNALS OF SURGICAL ONCOLOGY
- Effect of Metformin on Metabolic Improvement and Gut Microbiota
- (2014) Heetae Lee et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
- (2014) Hayato Nakagawa et al. CANCER CELL
- Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
- (2014) Monika Julia Wolf et al. CANCER CELL
- Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002-2012 United Network for Organ Sharing data
- (2014) Robert J. Wong et al. CLINICAL TRANSPLANTATION
- Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes
- (2014) Xiaodan Zhang et al. HEPATOLOGY
- Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
- (2014) Y.-L. Liu et al. JOURNAL OF HEPATOLOGY
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- Diabetes Mellitus and Poorer Prognosis in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
- (2014) Yan-Gang Wang et al. PLoS One
- TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
- (2014) Yang-Lin Liu et al. Nature Communications
- Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular Carcinoma
- (2013) L. Zheng et al. CLINICAL CANCER RESEARCH
- Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models
- (2013) Stephanie Coulon et al. HEPATOLOGY
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene
- (2013) Hwa-Li Tan et al. JOURNAL OF GASTROENTEROLOGY
- Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma
- (2013) Shingo Tanaka et al. JOURNAL OF GASTROENTEROLOGY
- Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
- (2013) Jessica Dyson et al. JOURNAL OF HEPATOLOGY
- Hepatic Stellate Cells Preferentially Induce Foxp3+ Regulatory T Cells by Production of Retinoic Acid
- (2013) R. M. Dunham et al. JOURNAL OF IMMUNOLOGY
- A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma
- (2013) Masato Fujii et al. Medical Molecular Morphology
- Failure Rates in the Hepatocellular Carcinoma Surveillance Process
- (2012) A. G. Singal et al. Cancer Prevention Research
- The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease
- (2012) Erin K. Daugherity et al. CELL CYCLE
- Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
- (2012) Donna L. White et al. Clinical Gastroenterology and Hepatology
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial
- (2012) Ann-Lii Cheng et al. EUROPEAN JOURNAL OF CANCER
- Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies
- (2012) Yi Chen et al. EUROPEAN JOURNAL OF CANCER
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
- (2012) Siddharth Singh et al. GASTROENTEROLOGY
- Fibrosis-dependent mechanisms of hepatocarcinogenesis
- (2012) David Y. Zhang et al. HEPATOLOGY
- Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH
- (2012) Lixin Zhu et al. HEPATOLOGY
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression
- (2012) JANINE KAH et al. ONCOLOGY REPORTS
- MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
- (2011) Z. Cao et al. CANCER RESEARCH
- Glucokinase Regulatory Protein Genetic Variant Interacts with Omega-3 PUFA to Influence Insulin Resistance and Inflammation in Metabolic Syndrome
- (2011) Pablo Perez-Martinez et al. PLoS One
- Inhibition of Autophagy Enhances Anticancer Effects of Atorvastatin in Digestive Malignancies
- (2010) P.-M. Yang et al. CANCER RESEARCH
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK
- (2010) Relja INTERNATIONAL JOURNAL OF ONCOLOGY
- Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus
- (2009) Rachel Huxley ARCHIVES OF INTERNAL MEDICINE
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
- (2009) Y. Hoshida et al. CANCER RESEARCH
- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
- (2009) Kittichai Promrat et al. HEPATOLOGY
- The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma
- (2008) J. Polesel et al. ANNALS OF ONCOLOGY
- Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
- (2008) D. Y. Chiang et al. CANCER RESEARCH
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells
- (2008) Bastian Hoechst et al. GASTROENTEROLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now